Insider · CIK 0001252522
GALAKATOS NICHOLAS
Reports to the SEC for 40 companies · CAMBRIDGE, MA
Transactions
50
Companies
40
Filings
10
CIK
0001252522
Forms 4 and 5
Insider transactions
| Date | Company | Value |
|---|---|---|
| 2019-06-19 | Entasis Therapeutics Holdings Inc.Stock Option (Right to Buy)A Award | — |
| 2019-03-25 | NS Wind Down Co., Inc.Common StockA Award | — |
| 2019-01-18 | Entasis Therapeutics Holdings Inc.Stock Option (right to buy)A Award | — |
| 2018-09-28 | Entasis Therapeutics Holdings Inc.C Conversion | — |
| 2018-09-28 | Entasis Therapeutics Holdings Inc.C Conversion | — |
| 2018-09-28 | Entasis Therapeutics Holdings Inc.Series B Convertible Preferred StockC Conversion | — |
| 2018-09-28 | Entasis Therapeutics Holdings Inc.Series B-1 Tranche B Convertible Preferred StockC Conversion | — |
| 2018-09-28 | Entasis Therapeutics Holdings Inc.P Purchase | +$6.8M |
| 2018-09-28 | Entasis Therapeutics Holdings Inc.C Conversion | — |
| 2018-09-28 | Entasis Therapeutics Holdings Inc.Series B-1 Tranche A Convertible Preferred StockC Conversion | — |
| 2018-09-17 | NS Wind Down Co., Inc.S Sale | −$1.37M |
| 2018-09-17 | NS Wind Down Co., Inc.Common Stock Warrant (Right to Buy)X Exercise of In-Money | — |
| 2018-09-17 | NS Wind Down Co., Inc.X Exercise of In-Money | +$1.37M |
| 2018-01-01 | NS Wind Down Co., Inc.Common StockA Award | — |
| 2017-01-01 | NS Wind Down Co., Inc.Stock Option (Right to Buy)A Award | — |
| 2016-09-27 | Radius Health, Inc.J Other | — |
| 2016-08-03 | ATXSAstria Therapeutics, Inc. · Stock Option (right to buy)A Award | — |
| 2016-01-11 | IVERIC bio, Inc.S Sale | −$65.4K |
| 2016-01-11 | IVERIC bio, Inc.S Sale | −$32.8K |
| 2016-01-11 | IVERIC bio, Inc.S Sale | −$66.4K |
| 2016-01-11 | IVERIC bio, Inc.S Sale | −$32.6K |
| 2016-01-01 | NS Wind Down Co., Inc.Stock Option (Right to Buy)A Award | — |
| 2015-12-10 | IVERIC bio, Inc.S Sale | −$17.1K |
| 2015-12-10 | IVERIC bio, Inc.S Sale | −$47.4K |
| 2015-12-10 | IVERIC bio, Inc.S Sale | −$94.8K |
| 2015-12-10 | IVERIC bio, Inc.S Sale | −$34.1K |
| 2015-11-18 | IVERIC bio, Inc.S Sale | −$30K |
| 2015-11-18 | IVERIC bio, Inc.S Sale | −$60K |
| 2015-11-10 | IVERIC bio, Inc.S Sale | −$29.3K |
| 2015-11-10 | IVERIC bio, Inc.S Sale | −$58.7K |
| 2015-11-09 | IVERIC bio, Inc.S Sale | −$30K |
| 2015-11-09 | IVERIC bio, Inc.S Sale | −$60K |
| 2015-11-02 | IVERIC bio, Inc.S Sale | −$27K |
| 2015-11-02 | IVERIC bio, Inc.S Sale | −$54K |
| 2015-06-30 | ATXSAstria Therapeutics, Inc. · Series B Preferred StockC Conversion | — |
| 2015-06-30 | ATXSAstria Therapeutics, Inc. · Stock Option (right to buy)A Award | — |
| 2015-06-30 | ATXSAstria Therapeutics, Inc. · Series A Preferred StockC Conversion | — |
| 2015-06-30 | ATXSAstria Therapeutics, Inc.P Purchase | +$4.52M |
| 2015-06-30 | ATXSAstria Therapeutics, Inc.C Conversion | — |
| 2015-06-30 | ATXSAstria Therapeutics, Inc.C Conversion | — |
| 2015-06-12 | IVERIC bio, Inc.G Gift | — |
| 2015-06-04 | IVERIC bio, Inc.Stock Option (Right To Buy)A Award | — |
| 2015-06-04 | IVERIC bio, Inc.Restricted Stock UnitsA Award | — |
| 2015-05-26 | IVERIC bio, Inc.J Other | — |
| 2015-05-26 | IVERIC bio, Inc.J Other | — |
| 2015-05-26 | IVERIC bio, Inc.J Other | — |
| 2015-01-01 | NS Wind Down Co., Inc.Stock Option (Right to Buy)A Award | — |
| 2014-06-27 | PORTOLA PHARMACEUTICALS INCStock Option (Right to Buy)A Award | — |
| 2014-02-26 | PORTOLA PHARMACEUTICALS INCJ Other | — |
| 2014-02-26 | PORTOLA PHARMACEUTICALS INCJ Other | — |
Recent filings
- 4GALAKATOS NICHOLAS0001104659-19-037000SEC(opens sec.gov)
- 4GALAKATOS NICHOLAS0001401708-19-000107SEC(opens sec.gov)
- 4GALAKATOS NICHOLAS0001209191-19-004766SEC(opens sec.gov)
- 4GALAKATOS NICHOLAS0001209191-18-053536SEC(opens sec.gov)
- 4GALAKATOS NICHOLAS0001401708-18-000121SEC(opens sec.gov)
- 4GALAKATOS NICHOLAS0001401708-18-000010SEC(opens sec.gov)
- 4NanoString Technologies Inc0001209191-17-001339SEC(opens sec.gov)
- 4Radius Health, Inc.0001209191-16-143186SEC(opens sec.gov)
- 4CATABASIS PHARMACEUTICALS INC0001104659-16-137597SEC(opens sec.gov)
- 4Ophthotech Corp.0001104659-16-089676SEC(opens sec.gov)
Companies
- ACHILLION PHARMACEUTICALS INC10% Owner
- AERIE PHARMACEUTICALS INC10% Owner
- AFFYMAX INCDirector, 10% Owner
- Altimmune, Inc.10% OwnerALT
- ALUS Liquidation Corp10% Owner
- ARYx Therapeutics, Inc.10% Owner
- Astria Therapeutics, Inc.DirectorATXS
- AVANIR PHARMACEUTICALS, INC.10% Owner
- AVEO PHARMACEUTICALS, INC.Director
- BARRIER THERAPEUTICS INC10% Owner
- CORNERSTONE THERAPEUTICS INCDirector, 10% Owner
- COTHERIX INC10% Owner
- CRYOCOR INC10% Owner
- Entasis Therapeutics Holdings Inc.Director
- EPIRUS Biopharmaceuticals, Inc.10% Owner
- Forty Seven, Inc.10% Owner
- GLOBUS MEDICAL INCManaging dir. of GPGMED
- HELICOS BIOSCIENCES CORP10% Owner
- HEMOSENSE INC10% Owner
- HUMANIGEN, INC10% Owner
- IVERIC bio, Inc.Director
- METABASIS THERAPEUTICS INC10% Owner
- NS Wind Down Co., Inc.Director, 10% Owner
- Oxford Immunotec Global PLC10% Owner
- Pernix Sleep, Inc.10% Owner
- Pharmasset Inc10% Owner
- PONIARD PHARMACEUTICALS, INC.10% Owner
- PORTOLA PHARMACEUTICALS INCDirector
- Praxis Precision Medicines, Inc.DirectorPRAX
- PROJECT SAGE OLDCO, INC.10% Owner
- Radius Health, Inc.Former 10% stockholder
- ReShape Weightloss Inc.Former 10% Owner
- RIGEL PHARMACEUTICALS INC10% OwnerRIGL
- SENORX INC10% Owner
- TERCICA INC10% Owner
- TETRALOGIC PHARMACEUTICALS Corp10% Owner
- Tourmaline Bio, Inc.DirectorTRML
- Venus Concept Inc.10% OwnerVERO
- VIACELL INC10% Owner
- ZOGENIX, INC.10% Owner
Address
C/O CLARUS VENTURES, LLC 101 MAIN STREET, SUITE 1210
CAMBRIDGE, MA, 02142